InvestorsHub Logo

la_trader

07/19/18 10:27 AM

#7250 RE: Curt D #7248

Less than 1% of OTCs have no toxic-debt, and less than .05% have BOTH no toxic-debt AND sales related net revenues significantly over one million annually.

FRLF is one of these rare emerging winners in this OTC marketplace. Most of these winners eventually up-list to big boards or are purchased by a bigger fish. All of the data, filings and consistent history of events supports the validity of the good investment we have found here.

FRLF is a well run and well managed company that is operating on actual cash flow and good deals made by the CEO. All of the rev streams they are building will produce multi-millions annually. the share structure is very tame and most shares are in the hands of strong core holders

Good luck and good trading to all. Know what you own.

mudpuppy

07/19/18 10:34 AM

#7251 RE: Curt D #7248

The company seems to be playing con games with their words.

from pr:
"has absolutely no toxic debt and no convertible note"

From latest 10Q:
"The Company is in the process of securing working capital from investors for common
stock......"
they even tell us that they distinguish different kinds of debt instruments:
"The Company evaluates its convertible debt, options, warrants or other contracts"

We can see in the filing there are millions of unexercised warrants outstanding.


So it appears they are continuing to do private placements which include warrants. This is Dilution, just not of the type called convertible note instruments.

So they are continuing to dilute the stock which pressures the price down. I would call that toxic equity debt but you can call it whatever you want.

We will not find out how much pp dilution they are selling now until the next filing which is not due until sept 30.